Rheumatoid arthritis market was valued at $54 billion in 2025 and is projected to reach $90 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026–2035). The rising global burden of autoimmune diseases is significantly strengthening demand for advanced rheumatoid arthritis therapeutics. Rheumatoid arthritis (RA), a chronic inflammatory disorder, continues to increase in prevalence due to aging populations, lifestyle risk factors, and improved diagnostic capabilities. The growing adoption of biologic and targeted synthetic therapies is transforming treatment outcomes and supporting long-term disease management.

Retinal disorders treatment market is projected to grow from $23.7 billion in 2025 to $44.5 billion by 2035, expanding at a CAGR of 6.5% during the forecast period (2026–2035). The market growth is primarily driven by the rising prevalence of vision impairment and retinal diseases, alongside advancements in biologics and gene-based therapies.

Rainwater harvesting market is projected to grow from $3.05 billion in 2025 to $5.56 billion by 2035, registering a CAGR of 6.2% during the forecast period (2026–2035). The market growth is strongly driven by increasing global water scarcity and rising demand for sustainable water management solutions across residential, commercial, and industrial sectors.

Sulphonamides market is projected to grow from $1.4 billion in 2025 to $2.2 billion by 2035, expanding at a CAGR of 4.6% during the forecast period. increasing prevalence of bacterial infections and the continued demand for cost-effective antimicrobial treatments are key factors driving market growth. Sulphonamides, known for their broad-spectrum antibacterial properties, remain widely used in both human and veterinary medicine.

Pregnancy care products market was valued at $2.65 billion in 2025 and is projected to reach $4.35 billion by 2035, growing at a CAGR of 5.1% during the forecast period (2026–2035). The increasing focus on maternal health and wellness, supported by rising awareness regarding prenatal and postnatal skincare, is significantly driving demand for pregnancy care products globally. Governments and healthcare organizations are actively promoting maternal health programs, encouraging the adoption of safe, dermatologically tested, and chemical-free personal care products during pregnancy. These factors are accelerating the adoption of stretch mark minimizers, breast care products, and intimate hygiene solutions across both developed and emerging economies.

Neuropathic pain treatment market was valued at $10.9 billion in 2025 and is projected to reach $19.2 billion by 2035, growing at a CAGR of 5.8% during the forecast period (2026–2035). The increasing global burden of chronic diseases, particularly diabetes and cancer, is significantly driving demand for neuropathic pain therapies. Neuropathic pain arises from nerve damage and is often chronic and difficult to treat, requiring long-term therapeutic management through pharmacological and non-pharmacological approaches. The growing aging population, coupled with the rising prevalence of nerve-related disorders, is further accelerating the demand for effective treatment solutions.

Macular degeneration treatment market was valued at $18.8 billion in 2025 and is projected to reach $33.7 billion by 2035, growing at a CAGR of 6.0% during the forecast period (2026–2035). The increasing global burden of age-related vision impairment, particularly among the aging population, is significantly driving demand for effective macular degeneration treatments. According to data from the National Institutes of Health (NIH), approximately 2.2 billion people globally suffer from vision impairment or blindness, with age-related macular degeneration (AMD) being a leading cause among individuals aged 60 years and above. This rising prevalence is accelerating the adoption of advanced therapeutic interventions, including anti-VEGF therapies and emerging biologics, thereby strengthening market growth.

Large caliber ammunition market was valued at $14.50 billion in 2025 and is projected to reach $26.31 billion by 2035, growing at a CAGR of 6.1% during the forecast period (2026–2035). The rising geopolitical tensions and increasing defense modernization programs across major economies are significantly strengthening demand for large-caliber ammunition. Governments globally are increasing military budgets to enhance combat readiness, territorial security, and deterrence capabilities, driving procurement of advanced artillery, tank, and naval ammunition systems. Large caliber ammunition plays a critical role in long-range strike capabilities, firepower superiority, and operational effectiveness, thereby supporting sustained demand across land, naval, and air defense platforms.

IoT node and gateway market is projected to grow from $85 billion in 2025 to $183 billion by 2035, expanding at a CAGR of 8.0% during the forecast period. The market growth is primarily driven by the rapid expansion of connected infrastructure and industrial digitalization. Among hardware segments, Connected Integrated Circuits (ICs) are witnessing the fastest growth due to their critical role in enabling wireless communication (Wi-Fi, Bluetooth, LPWAN, 5G) across IoT ecosystems. Increasing demand for low-power connectivity and edge intelligence is driving innovation and strategic developments in this segment. From an application standpoint, the proliferation of smart energy systems and electric mobility is further reinforcing the need for IoT hardware. According to the International Renewable Energy Agency, renewable energy capacity additions reached over 500 GW globally in 2023, requiring advanced monitoring systems enabled by IoT nodes and gateways.

Incubator devices market was valued at $3.82 billion in 2025 and is projected to reach $7.19 billion by 2035, growing at a CAGR of 6.5% during the forecast period (2026–2035). The market growth is primarily driven by the rising global burden of preterm births and increasing demand for advanced laboratory research infrastructure. According to the World Health Organization (WHO), an estimated 15 million babies are born preterm every year globally, accounting for more than 1 in 10 births. This has significantly increased the need for technologically advanced neonatal incubators capable of providing controlled thermal environments, thereby supporting survival rates and neonatal care outcomes.